Evidence map›Paper›PMID 41122113›Full record

ArticleCurrent medical mycology2025

Development and characterization of

Iman Haghani, Mahdi Abastabar, Mahmoud Osanloo, Ali Davoodi, Amirhossein Ghasemzadeh, Masoumeh Eslamifar, Emran Habibi, Javad Akhtari

Abstract read
In one paragraph

Article in Current medical mycology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Iman HaghaniInvasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Mahdi AbastabarInvasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Mahmoud OsanlooDepartment of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Ali DavoodiMedicinal Plants Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Amirhossein GhasemzadehStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Masoumeh EslamifarDepartment of Environmental Health Engineering, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran.
Emran HabibiMedicinal Plants Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Javad AkhtariMolecular and Cell Biology Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Essential oils (EO) have gained significant attention due to their natural antimicrobial and antifungal properties. However, their application is often limited due to poor solubility, volatility, and stability. Nanoemulsions, as advanced delivery systems, can overcome these limitations by enhancing the bioavailability and efficacy of EOs. Lemon EO, known for its broad-spectrum antimicrobial activity, is a promising candidate for nanoemulsion formulation. This study aimed to synthesize and characterize lemon EO nanoemulsions and evaluate their enhanced antimicrobial and antifungal potential, compared to crude oil. Materials and Methods: Lemon EO was first analyzed using gas chromatography-mass spectrometry (GC-MS) to identify its chemical composition. Lemon EO nanoemulsions were prepared using the spontaneous emulsification technique. The physicochemical properties, including particle size, polydispersity index (PDI), zeta potential, and stability, were characterized using dynamic light scattering. The antimicrobial and antifungal activities were assessed against Results: The GC-MS analysis revealed the major chemical components of lemon EO, including limonene, β-pinene, and γ-terpinene. The nanoemulsions exhibited a mean particle size of about 15 nm, a low PDI (< 0.3), and a negative zeta potential, indicating high stability and homogeneity. The antimicrobial and antifungal activities of the nanoemulsions were significantly enhanced compared to the crude lemon EO, as demonstrated by lower MIC and MFC values. The nanoemulsions also showed excellent stability under various storage conditions. Conclusion: This study demonstrated that lemon EO nanoemulsions are a stable delivery system with superior antimicrobial and antifungal properties. The GC-MS analysis provided valuable insights into the chemical composition of the EO, further supporting its efficacy. These findings suggest the potential of lemon EO nanoemulsions as a natural alternative for applications in food preservation, pharmaceuticals, and cosmetics.

Indexed as

Citrus limon (L.) OsbeckEssential oilLiposomeNanoNanoemulsion

Identifiers

PMID41122113
PMCPMC12536814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.